114 results · 17ms · Sources: EU EUDAMED, US FDA

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

Immunohistochemistry Antibody Assay, C-Kit

FDA Pre-Market Approval
FDA Class 3 ·C-KIT PHARMDX

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT™ Venous Endoprosthesis with Unistep Plus™ Delivery System

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·Wallstent Venous RP & Endoprosthesis with Unistep Plus

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

Immunohistochemistry Antibody Assay, C-Kit

FDA Pre-Market Approval
FDA Class 3 ·C-Kit pharmDx

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT (TIPS,ILAC,VENOUS)ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT ENDOPROSTHESIS (VENOUS)

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Immunohistochemistry Antibody Assay, C-Kit

FDA Pre-Market Approval
FDA Class 3 ·PATHWAY ANTI-C-KIT (9.7) RABBIT MONOCLONAL PRIMARY ANTIBODY

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·Wallstent (Venous) Endoprosthesis with Unisteo Plus Delivery System

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT (VENOUS)ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Immunohistochemistry Antibody Assay, C-Kit

FDA Pre-Market Approval
FDA Class 3 ·PATHWAY ANTI-C-KIT (9.7) RABBIT MONOCLONAL PRIMARY ANTIBODY

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·Wallstent Venous Endoprosthesis with Unistep Plus™ Delivery System

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·Wallstent Venous Endoprosthesis with UNISTEP Plus

Immunohistochemistry Antibody Assay, C-Kit

FDA Pre-Market Approval
FDA Class 3 ·PATHWAY ANTI-C-KIT (9.7) RABBIT MONOCLONAL PRIMARY ANTIBODY

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT ENDO (VENOUS) STENT SYTEM